A detailed history of Castleview Partners, LLC transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Castleview Partners, LLC holds 105 shares of DGX stock, worth $14,394. This represents 0.01% of its overall portfolio holdings.

Number of Shares
105
Previous 72 45.83%
Holding current value
$14,394
Previous $9,000 55.56%
% of portfolio
0.01%
Previous 0.01%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$137.09 - $137.09 $4,523 - $4,523
33 Added 45.83%
105 $14,000
Q2 2024

Jul 31, 2024

BUY
$125.91 - $144.34 $3,525 - $4,041
28 Added 63.64%
72 $9,000
Q1 2024

May 09, 2024

BUY
$123.78 - $142.11 $2,723 - $3,126
22 Added 100.0%
44 $5,000
Q4 2023

Feb 05, 2024

BUY
$120.62 - $141.12 $2,653 - $3,104
22 New
22 $3,000
Q2 2023

Aug 14, 2023

BUY
$130.56 - $146.84 $6,528 - $7,342
50 New
50 $7,000
Q1 2022

May 16, 2022

SELL
$129.09 - $164.35 $1.67 Million - $2.13 Million
-12,975 Closed
0 $0
Q4 2021

Feb 17, 2022

BUY
$140.36 - $173.01 $1.82 Million - $2.24 Million
12,975 New
12,975 $2.24 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Castleview Partners, LLC Portfolio

Follow Castleview Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleview Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleview Partners, LLC with notifications on news.